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The Effect of Iliac Crest Autograft on the Outcome of
Fusion in the Setting of Degenerative Spondylolisthesis
A Subgroup Analysis of the Spine Patient Outcomes Research Trial (SPORT)
Kristen Radcliff, MD, Raymond Hwang, MD, MEng, MBA, Alan Hilibrand, MD, Harvey E. Smith, MD, Jordan Gruskay, BS,
Jon D. Lurie, MD, MS, Wenyan Zhao, PhD, Todd Albert, MD, and James Weinstein, DO, MS
Investigation performed at the Rothman Institute, Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia,
Pennsylvania; Department of Orthopaedic Surgery, Tufts University School of Medicine, and New England Baptist
Hospital, Boston, Massachusetts; and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Background: There is considerable controversy about the long-term morbidity associated with the use of posterior
autologous iliac crest bone graft for lumbar spine fusion procedures compared with the use of bone-graft substitutes. The
hypothesis of this study was that there is no long-term difference in outcome for patients who had posterior lumbar fusion
with or without iliac crest autograft.
Methods: The study population includes patients enrolled in the degenerative spondylolisthesis cohort of the Spine
Patient Outcomes Research Trial who underwent lumbar spinal fusion. Patients were divided according to whether they
had or had not received posterior autologous iliac crest bone graft.
Results: There were 108 patients who had fusion with iliac crest autograft and 246 who had fusion without iliac crest
autograft. There were no baseline differences between groups in demographic characteristics, comorbidities, or baseline
clinical scores. At baseline, the group that received iliac crest bone graft had an increased percentage of patients who had
multilevel fusions (32% versus 21%; p = 0.033) and L5-S1 surgery (37% versus 26%; p = 0.031) compared with the group
without iliac crest autograft. Operative time was higher in the iliac crest bone-graft group (233.4 versus 200.9 minutes; p <
0.001), and there was a trend toward increased blood loss (686.9 versus 582.3; p = 0.057). There were no significant
differences in postoperative complications, including infection or reoperation rates, between the groups. On the basis of
the numbers available, no significant differences were detected between the groups treated with or without iliac crest
bone graft with regard to the scores on Short Form-36, Oswestry Disability Index, Stenosis Bothersomeness Index, and
Low Back Pain Bothersomeness Scale or the percent of patient satisfaction with symptoms averaged over the study
period.
Conclusions: The outcome scores associated with the use of posterior iliac crest bone graft for lumbar spinal fusion
were not significantly lower than those after fusion without iliac crest autograft. Conversely, iliac crest bone-grafting was
not associated with an increase in the complication rates or rates of reoperation. On the basis of these results, surgeons
may choose to use iliac crest bone graft on a case-by-case basis for lumbar spinal fusion.
Level of Evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

Disclosure: One or more of the authors received payments or services,
either directly or indirectly (i.e., via his or her institution), from a third
party in support of an aspect of this work. In addition, one or more of
the authors, or his or her institution, has had a financial relationship, in
the thirty-six months prior to submission of this work, with an entity in
the biomedical arena that could be perceived to influence or have the
potential to influence what is written in this work. Also, one or more of
the authors has had another relationship, or has engaged in another
activity, that could be perceived to influence or have the potential to
influence what is written in this work. The complete Disclosures of
Potential Conflicts of Interest submitted by authors are always provided with the online version of the article.

J Bone Joint Surg Am. 2012;94:1685-92

d

http://dx.doi.org/10.2106/JBJS.K.00952

This article was chosen to appear
electronically on August 8, 2012, in
advance of publication in a regularly
scheduled issue.

1686
TH E JO U R NA L O F B O N E & JO I N T SU RG E RY J B J S . O RG
V O L U M E 94-A N U M B E R 18 S E P T E M B E R 19, 2 012
d

d

d

D

egenerative spondylolisthesis is the most common form
of spondylolisthesis. For patients who undergo surgery, achieving a solid lumbar spinal fusion is of
paramount clinical importance1,2. Iliac crest autograft has been
commonly used for achieving a fusion in lumbar spine surgery3-5.
However, short and long-term morbidity associated with iliac
crest bone-graft harvest is a concern to many surgeons and
patients6-9.
The Spine Patient Outcomes Research Trial (SPORT) includes a prospective, randomized study of patients treated for
degenerative spondylolisthesis. These data provide an opportunity to compare the outcomes of patients who underwent fusion
with or without the use of iliac crest autograft. The purpose of
this study was to compare the complications and change in
primary outcome measures between patients who underwent
fusion with or without autologous iliac crest bone graft. This
study may aid in clinical decision making for patients and
physicians about the outcomes and complications of iliac crest
bone-grafting for surgical treatment of degenerative spondylolisthesis. The specific issues addressed in this study were (1)
whether there is a difference in the change in clinical outcome
measures between patients who did or did not undergo autogenous iliac crest bone-grafting, (2) whether there is a difference
in perioperative complications between patients who did or
did not undergo autogenous iliac crest bone-grafting, and (3)
whether there is a difference in the revision rate between patients
who did or did not undergo autogenous iliac crest bone-grafting.
Materials and Methods
Study Design

T

his investigation was a subgroup analysis of a prospective study with randomized and observational arms. The SPORT was conducted in eleven
states at thirteen multidisciplinary spine practices across the United States. The
trial was registered at ClinicalTrials.gov under registry number NCT00000409.
Methods and additional background information have been well described in
10,11
previous publications
.

Patient Population
The population of this study includes patients enrolled in the degenerative
spondylolisthesis cohort of SPORT who underwent spinal fusion. The human
subject committees at each center approved the standardized protocol. All
patients fit the following inclusion criteria: an age of over eighteen years with
twelve weeks of persistent radicular pain with associated neurologic deficit and/
or neurogenic claudication, confirmatory cross-sectional imaging showing
spinal stenosis and lateral radiographs showing degenerative spondylolisthesis,
and physician confirmation as a surgical candidate. Patients with adjacent levels
of stenosis were eligible, but those with spondylolysis and isthmic spondylolisthesis were not. Exclusion criteria included progressive neurological deficit or
cauda equina syndrome, active malignancy, scoliosis measuring >15°, prior
back surgery, and other established contraindications to elective surgery. Enrollment began in March 2000 and ended in February 2005. Patients with
scoliosis measuring >15° were excluded to avoid the confounding effect of
complex, multilevel deformity reconstruction. Patients in the study population
were specifically selected for treatment of neurological symptoms due to degenerative spondylolisthesis, and the investigators thought that inclusion of
patients with a major deformity may confound decision making for surgical
versus nonsurgical treatment and selection of fusion levels.
The study population included all patients who were surgically treated,
whether they were originally enrolled in the randomized or observational co-
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horts. Patients in the original study who met the inclusion criteria were offered
the choice of randomization or enrollment into an observational cohort study
for treatment of degenerative spondylolisthesis. Patients in the randomized
cohort were randomly assigned to either surgical or nonsurgical treatment.
Patients in the observational cohort chose surgical or nonsurgical treatment.
For the purposes of this subgroup analysis, all of the patients who underwent
surgery were combined into an as-treated analysis. The nonsurgically treated
patients were excluded, and the surgically treated patients were considered the
study population. Patients were then subdivided according to whether they had
or had not undergone autologous iliac crest bone-grafting.

Study Interventions
The protocol surgery used in this study population consisted of a standard
posterior decompressive laminectomy with an additional bilateral lumbar spinal
fusion. The fusion was performed with posterior iliac crest autograft, morselized
allograft, local bone graft, or bone-graft substitutes. Fusions were performed with
or without the use of instrumentation according to the clinical judgment of the
surgeon. There was no standardized iliac crest bone-graft harvest protocol.

Study Measures
Data used in this study were obtained prospectively and reviewed retrospectively from patient questionnaires completed at baseline, six weeks, three
months, six months, one year, two years, three years, and four years following
surgery. Primary outcome measures were the Short Form-36 (SF-36) outcome
12
instrument , including the physical function and bodily pain subscales and the
13
physical component summary score, and the Oswestry Disability Index .
Secondary measures included satisfaction with current symptoms, the
Stenosis Bothersomeness Index, the Low Back Pain Bothersomeness Scale, and
14
14
the Leg Pain Bothersomeness Scale . These indices consist of four questions
regarding pain, numbness, weakness, and walking difficulty during the previous week scored on a 0 to 6-point scale. The SF-36 scores and the Oswestry
Disability Index range from 0 to 100; the Leg Pain Bothersomeness Scale and
the Low Back Pain Bothersomeness Scale, from 0 to 6; and the Stenosis
Bothersomeness Index, from 0 to 24. Higher scores indicate less severe
symptoms on the SF-36, whereas higher scores indicate more severe symptoms
on the Oswestry Disability Index, the Stenosis Bothersomeness Index, the Leg
13
Pain Bothersomeness Scale, and the Low Back Pain Bothersomeness Scale .
Since there are no specific outcome measures, to our knowledge, for iliac crest
donor-site morbidity, we postulated that the Low Back Pain and Leg Pain
Bothersomeness indices would be sensitive tools to identify and quantify donorsite morbidity. Donor-site morbidity has been shown in other studies to present
15-18
as residual back or leg pain
. The bothersomeness indices specifically inquire
about the intensity of symptoms of back or lower-extremity pain, in contrast to
general health-related quality-of-life measures (for example, the SF-36) or functional
measures (for example, the Oswestry Disability Index) that may not be sensitive to
donor-site pain that does not limit function.
Change in outcome was adjusted for age, sex, work status, body mass
index, stenosis, hypertension, depression, osteoporosis, joint problems, current
symptom duration, lower-extremity reflex deficit, number of moderately or
severely stenotic vertebral levels, treatment preference, other comorbidity,
baseline score (for SF-36 and Oswestry Disability Index), baseline Stenosis
Bothersomeness Index, and center.

Statistical Analysis
Baseline characteristics between the groups managed with or without iliac crest
bone-grafting were compared with use of a chi-square test for categorical
variables and t tests for continuous variables. Outcome analyses were per10,11
formed as they were done in the primary SPORT papers
. Outcomes were
analyzed with use of longitudinal mixed-effects models with a random individual effect to account for the correlation among repeated observations within
individuals over time. Adjusting covariates that were found to predict missing
data, treatment received, and outcome were included in the model (details of
the covariate selection process have been described in the SPORT primary
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TABLE I Operative Treatments, Complications, and Events
Group Treated without Iliac
Crest Autograft (N = 246)

Group Treated with Iliac
Crest Autograft (N = 108)

P Value

Procedure (no. of patients)
Noninstrumented fusion
Instrumented fusion
Multilevel fusion

56 (23%)
190 (77%)
52 (21%)

22 (20%)
86 (80%)
35 (32%)

0.033

Decompression level (no. of patients)
L2-L3
L3-L4
L4-L5
L5-S1

31 (13%)
123 (50%)
234 (95%)
63 (26%)

9 (8%)
45 (42%)
107 (99%)
40 (37%)

0.33
0.20
0.076
0.031

No. of levels decompressed (no. of patients)
0
1
2
‡3

2 (1%)
103 (42%)
89 (36%)
52 (21%)

1 (1%)
44 (41%)
37 (34%)
26 (24%)

Operative time* (min)

200.9 (85.7)

233.4 (70.6)

Blood loss* (mL)

582.3 (451.2)

686.9 (523.7)

0.057

83 (34%)
53 (22%)
4.8 (3)†

45 (42%)
24 (22%)
4.8 (2.1)

0.22
0.96
0.96

Intraoperative complications‡ (no. of patients)
Dural tear and/or spinal fluid leak
Vascular injury
Other
None

22 (9%)
1 (0.4%)
6 (2%)
218 (89%)

11 (10%)
0 (0%)
1 (1%)
96 (89%)

0.86
0.67
0.60
0.91

Postoperative complications or events§ (no. of patients)
Nerve root injury
Wound hematoma
Wound infection
Other
None

1 (0%)
0 (0%)
5 (2%)
25 (10%)
171 (70%)

0 (0%)
1 (1%)
6 (6%)
9 (8%)
69 (64%)

0.68
0.68
0.16
0.71
0.28

0 (0%)

1
0.834
0.743
0.562
0.755

Blood replacement (no. of patients)
Intraoperative replacement
Postoperative transfusion
Length of hospital stay* (days)

Postoperative mortality (no. of patients)
Within 3 mo of surgery

0.72

0.94

1 (0.4%)

Additional surgeries# (no. of patients)
1-year rate
2-year rate
3-year rate
4-year rate

15 (6%)
28 (11%)
33 (13%)
35 (14%)

6 (6%)
11 (10%)
12 (11%)
14 (13%)

Reason for additional surgery** (no. of patients)
Recurrent stenosis or progressive listhesis
Pseudarthrosis or fusion exploration
Infection
Other
New condition

11 (4%)
3 (1%)
5 (2%)
12 (5%)
5 (2%)

4 (4%)
1 (1%)
4 (4%)
5 (5%)
3 (3%)

<0.001

*The values are given as the mean, with the standard deviation in parentheses. †One of the patients in the group treated without iliac crest autograft had a
length of hospital stay of 372 days—not counting that patient, the average length of hospital stay (and standard deviation) for that group would be 4.8 (3).
‡No cases of aspiration into the respiratory tract, nerve-root injury, or operation at wrong level were reported. §Complications or events occurring up to eight
weeks after surgery are listed. There were no reported cases of bone-graft complication, cerebrospinal fluid leak, paralysis, cauda equina injury,
pseudarthrosis, or wound dehiscence. #One, two, three, and four-year reoperation rates are Kaplan-Meier estimates, and p values are based on the logrank test. Numbers and percentages are based on the first additional surgery if more than one additional surgery. Surgeries include any additional spine
surgery—not just a reoperation at the same level. **Several patients underwent more than one reoperation.
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TABLE II Analysis of Results from the Adjusted As-Treated Analyses According to Bone-Graft Source*
1 Year
Group Treated
without Iliac
Crest Autograft
(N = 192)†
Short Form-36 scores‡§
Bodily pain
Physical function
Physical component summary
Mental component summary
Oswestry Disability Index score‡#

32.4 (1.7)
29.9 (1.6)
12.5 (0.68)
2.6 (0.65)
225.5 (1.3)

Group Treated
with Iliac
Crest Autograft
(N = 83)†

P Value

35.5 (2.6)
32 (2.5)
13.8 (1)
4.2 (1)

0.32
0.49
0.31
0.18

Group Treated
without
Iliac Crest Autograft
(N = 224)†

31.4 (1.7)
26.8 (1.6)
12 (0.68)
2.5 (0.65)

Group Treated
with Iliac
Crest Autograft
(N = 102)†

31.9 (2.7)
28.9 (2.6)
12.4 (1.1)
3.2 (1.1)

0.88
0.50
0.78
0.57

227.7 (2)

0.35

224.1 (1.3)

0.43

29 (0.43)

29.8 (0.69)

0.40

22.4 (0.1)

22.5 (0.2)

0.78

22.1 (0.1)

22.2 (0.2)

0.76

23.1 (0.1)

23 (0.2)

0.80

22.9 (0.1)

23.1 (0.2)

0.41

0.61

66.2

29.6 (0.43)

Low Back Pain Bothersomeness
Scale score‡††
Leg Pain Bothersomeness Scale
score‡‡‡

71.4

69.4

226.7 (2.1)

P Value

210.3 (0.66)

Stenosis Bothersomeness Index
score‡**

Patients very or somewhat
satisfied with symptoms (%)

2 Year

63.2

0.29

0.77

*Adjusted for age, sex, work status, body mass index, any neuroforamen (L or R), hypertension, depression, osteoporosis, joint problems, current
symptom duration, reflex deficit, number of moderately or severely stenotic levels, treatment preference, other comorbidity (problems related to
stroke, cancer, lung, fibromyalgia, chronic fatigue syndrome, posttraumatic stress disorder, alcohol, drug dependency, liver, kidney, blood vessel,
nervous system, migraine, or anxiety), baseline score (for Short Form-36 [SF-36] and Oswestry Disability Index), baseline stenosis bothersomeness, and center. †The sample sizes for the as-treated analyses reflect the number of patients contributing to the estimate in a given time
period with use of the longitudinal modeling strategy explained in the Materials and Methods section. ‡The values are given as the mean score,
with the standard error of the mean in parentheses. §The SF-36 scores range from 0 to 100, with higher scores indicating less severe symptoms.
#The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms. **The Stenosis Bothersomeness Index
ranges from 0 to 24, with lower scores indicating less severe symptoms. ††The Low Back Pain Bothersomeness Scale ranges from 0 to 6, with
lower scores indicating less severe symptoms. ‡‡The Leg Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less
severe symptoms.

10,11

papers
). In addition, baseline outcome, center, age, and sex were included
in all longitudinal outcome models. All analyses were as-treated, and treatment
was considered a time-varying covariate. Therefore, patients were categorized
at each time point as to whether they received surgical treatment, follow-up
times were measured from the beginning of treatment, and baseline covariates
were updated at the time of surgery. Secondary and binary outcomes were
analyzed with use of generalized estimating equations assuming a compound
symmetry working correlation structure. Analyses were performed with the use
of the PROC MIXED procedure for continuous data and the PROC GENMOD
procedure for binary and non-normal secondary outcomes from the SAS
software package (version 9.2; SAS Institute, Cary, North Carolina). Statistical
significance was defined as p < 0.05 on the basis of a two-sided hypothesis with
no adjustment made for multiple comparisons.
One, two, three, and four-year postsurgical reoperation rates are KaplanMeier estimates, and p values are based on the log-rank test. Numbers and
percentages are based on the first additional surgery if there was more than one
additional surgery. Surgeries include any additional spine surgery (not just reoperation at the same level).

Source of Funding
The authors acknowledge funding from the following sources: the National
Institute of Arthritis and Musculoskeletal and Skin Diseases (U01-AR45444)
and the Office of Research on Women’s Health, the National Institutes of
Health, and the National Institute of Occupational Safety and Health, the
Centers for Disease Control and Prevention.

Results
total of 354 patients, including 246 who had not had iliac
crest bone-grafting and 108 who had iliac crest bonegrafting, were identified. Baseline characteristics are reported
in the Appendix. There were no significant baseline differences
in primary or secondary outcome measures (SF-36, Oswestry
Disability Index, Stenosis Bothersomeness Index, and Low
Back Pain Bothersomeness Scale) between the groups managed
with or without iliac crest bone-grafting. There were significant
differences in clinical presentation between the groups. Compared with the group without iliac crest bone graft, the group
that had iliac crest bone-grafting had an increased percentage
of patients with a neurological deficit (65% versus 50%; p =
0.011), asymmetric depressed lower-extremity reflexes (35%
versus 22%; p = 0.017), and neuroforaminal stenosis (51%
versus 39%; p = 0.041). There was a significant increase (p =
0.043) in the percentage of patients with three or more stenotic
vertebral levels in the group that had not had iliac crest bonegrafting than in the group that had iliac crest bone-grafting (8%
versus 1%).
Operative details are reported in Table I. Compared with
the group that had not had iliac crest bone-grafting, the patients

A
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TABLE II (continued)
3 Year
Group Treated
without Iliac
Crest Autograft
(N = 209)†

32.2 (1.7)
25.8 (1.7)
11.7 (0.71)
1.9 (0.68)

Group Treated
with Iliac
Crest Autograft
(N = 94)†

32.5 (2.7)
27.7 (2.6)
11.7 (1.1)
3.2 (1.1)

4 Year

P Value

Group Treated
without Iliac
Crest Autograft
(N = 174)†

0.91
0.55
1
0.31

30.8 (1.8)
27.5 (1.7)
11.2 (0.75)
2 (0.73)

30.3 (2.9)
27.5 (2.8)
11.9 (1.2)
3 (1.2)

0.88
0.99
0.65
0.48

222.6 (2.1)

0.96

29 (0.45)

29.9 (0.7)

0.32

29.4 (0.46)

29.2 (0.75)

0.82

22.1 (0.1)

22.1 (0.2)

0.98

22.2 (0.1)

22.3 (0.2)

0.57

22.9 (0.1)

23.3 (0.2)

0.07

23.1 (0.1)

23.1 (0.2)

0.82

58.4

0.39

who received iliac crest autograft were more likely to have a
multilevel fusion (32% versus 21%; p = 0.033) and decompression of L5-S1 (37% versus 26%; p = 0.031). Procedures
performed with iliac crest autograft were also significantly
longer (mean, 233.4 minutes versus 200.9 minutes; p < 0.001).
Intraoperative blood loss in the iliac crest autograft group
trended higher (mean, 686.9 versus 582.3 mL), but the difference did not reach significance (p = 0.057). The rate of
intraoperative blood replacement was not significantly different
between the groups (42% of 108 patients treated with iliac
crest autograft and 34% of 246 treated without iliac crest
autograft; p = 0.22). The rate of postoperative blood trans-

59.4

225.4 (2.2)

P Value

222.7 (1.3)

63

223 (1.4)

Group Treated
with Iliac
Crest Autograft
(N = 74)†

62.4

0.38

0.91

fusions was not significantly different between the groups
(22% in both; p = 0.96). There was no significant difference in
the use of spinal instrumentation between groups (80% and
77%, respectively; p = 072). There was no significant difference in length of hospital stay between groups (4.8 days in
both; p = 0.96). There were no significant differences between
groups with regard to postoperative complications, including
wound hematoma (1% and 0%, respectively; p = 0.68),
wound infection (6% and 2%; p = 0.16), postoperative
mortality within three months of surgery (0% and 0.4%; p =
1), or other complications (8% and 10%; p = 0.71). There
were no significant differences in the rate of additional

Fig. 1

Graphs showing the primary outcomes over time by bone-graft source and the p values for the comparison of the groups with or without iliac crest autograft
with respect to the time-weighted average four-year area under the curve. The I bars indicate the standard deviation.
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TABLE III Average Four-Year Area Under the Curve Estimates
Group Treated without
Iliac Crest Autograft*
Short Form-36
Bodily pain
Physical function
Physical component summary
Mental component summary
Oswestry Disability Index
Stenosis Bothersomeness Index

30.8 (1.2)
26 (1.2)
11.4 (0.5)
2.4 (0.4)

Group Treated with Iliac
Crest Autograft*

31.4 (1.9)
27.6 (1.9)
11.6 (0.8)
3.5 (0.7)

223.1 (1)
28.9 (0.3)

P Value

0.80
0.51
0.77
0.20

224.6 (1.5)

0.43

29.5 (0.5)

0.40

*The values are given as the average, with the standard deviation in parentheses.

surgical procedures between the groups at one year (6% of
108 patients treated with iliac crest autograft and 6% of 246
patients treated without iliac crest autograft; p = 0.834) or at
two (10% and 11%, respectively; p = 0.743), three (11% and
13%; p = 0.562), or four years (13% and 14%; p = 0.755).
Changes in the primary outcome measures at all time
points are illustrated in Table II and Figure 1. On the basis of
the numbers available, there were no significant differences
between the groups with respect to primary or secondary
outcome measures at any time point. The area under the curve
estimates for change in primary and secondary outcome
measures were not significantly different between the groups
(Table III).
A post hoc power analysis was conducted with use of t
tests for two samples to determine the minimum effect that the
study was powered to detect, given the observation of no significant difference between groups19. On the basis of the sample
sizes and standard deviations observed in the four-year area
under the curve data, there was 80% power to detect a difference in the score of 0.6 for SF-36 bodily pain, 0.6 for SF-36
physical function, 0.3 for SF-36 physical component summary,
0.2 for SF-36 mental component summary, 0.5 for the Oswestry
Disability Index, and 0.2 for the Stenosis Bothersomeness
Index.
Discussion
hese findings suggest that the use of autogenous iliac crest
bone graft in fusion for degenerative spondylolisthesis does
not result in a worse outcome or increased complications than
that after fusion without iliac crest autograft. In the current study,
on the basis of the numbers available, there was no difference
in general or disease-specific health outcome measures between
the groups treated with or without iliac crest bone-grafting. There
was no difference between groups with respect to the presence of
symptomatic pseudarthrosis requiring reoperation. On the basis
of the length of hospital stay, intraoperative complications, postoperative complications, and reoperation rate, the postoperative
courses of the groups were nearly identical.
There is considerable controversy with regard to the reported incidence and severity of complications related to iliac
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crest bone-graft harvesting. Some studies have demonstrated
that the use of iliac crest bone graft has substantial donor-site
morbidity6,7,16,17,20-23. However, other authors have reported that
assessment of iliac crest donor-site pain is overestimated15,24 and
confounded by the concomitant pain from lumbar radiculopathy17,18,25,26. Our results are consistent with previous studies
that have found no long-term morbidity or worsening in outcome after iliac crest bone-graft harvest.
The strengths of this study include the large study population and the long-term follow-up (four years). To our
knowledge, the current study is the largest study in the literature and includes a broad array of general, back, and leg painspecific outcome measures, in contrast to previous studies. On
the basis of the post hoc power analysis, the magnitude of the
difference observed in SF-36 bodily pain, physical function,
and physical component summary scores and the Oswestry
Disability Index was equal to or less than that of the minimum
detectable effect size, given the sample sizes between groups19.
Furthermore, the magnitude of difference between the groups
was less than the minimum clinically important difference
between the groups with regard to the SF-36 and Oswestry
Disability Index27.
The limitations of this study include the fact that it was a
retrospective subgroup analysis that was not specified a priori.
There is a possibility of unknown confounders biasing the
results, such as sagittal balance or surgeon experience with
bone-grafting techniques. Also, a heterogeneous group of bonegrafting techniques was used, even for autologous iliac crest
bone-graft harvest. There was no standardization of iliac crest
bone-graft harvest techniques. While scar and paresthesias may
be associated with incision and approach, donor-site pain is
arguably mostly osseous in nature and dependent more on the
presence or absence of iliac crest harvesting. To the extent that
these donor-site issues are disabling, we would expect that their
effects would be incorporated into the outcome measures. More
multilevel spinal fusions occurred in patients who had iliac crest
bone-grafting than in those who had not (32% versus 21%; p =
0.033). It may be that surgeons chose iliac crest bone-grafting
for patients undergoing multilevel fusion to offset the higher risk
of pseudarthrosis in the multilevel fusion group. The difference
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between the groups with respect to fusion levels and stenosis
levels may account for the increased operative time and trend
toward increased blood loss in the group that had iliac crest
bone-grafting. Surgery at L5-S1 was more likely to have iliac crest
bone graft, possibly because of the known increased risk of
pseudarthrosis at that level. Another limitation of this study is
the exact nature of the graft used in the group treated without
iliac crest bone-grafting. Because this was not specified within
SPORT, it therefore could not be separately analyzed in this study
to directly compare iliac crest bone-graft substitutes, including
local autograft, allograft, synthetic agents, or bone morphogenic
protein. However, such heterogeneity is reflective of actual
clinical practice, with decisions to augment local bone with allograft as needed on the basis of the surgeon’s judgment. Since
the primary research question was the difference in outcome
after fusion with or without the use of iliac crest autograft, we do
not believe this limitation hinders the ability to draw conclusions
regarding the use of iliac crest bone graft compared with substitutes for iliac crest bone graft. It should be noted that among
patients undergoing fusion in situ, the use of iliac crest bone graft
might have held greater importance in preventing the development of a symptomatic nonunion. Another limitation is the lack
of radiographic assessment of spinal fusion between the groups.
The SPORT database does not include postoperative radiographs
or the surgeons’ assessment of fusion. As an indirect marker of
success of lumbosacral fusion, we report that there was no significant difference in reoperation rates between the groups
managed with or without iliac crest bone graft. To the extent that
pseudarthrosis is a clinically important event, we would expect
pseudarthrosis to be reflected in either clinical outcome scores or
reoperation rates. The degenerative spondylolisthesis cohort in
the present study had a reoperation rate of 1% for symptomatic
nonunions. This is far lower than reported nonunion rates for
both instrumented8,22,28,29 and noninstrumented23,29 fusions of the
lumbar spine. We recognize this disparity and consider that this
rate represents the rate of reoperation for symptomatic pseudarthrosis, whereas previous studies have described reoperation
for asymptomatic radiographic pseudarthrosis.
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In conclusion, the results of this study demonstrate similar
outcomes of lumbar spinal fusion with or without the use of iliac
crest bone graft in patients with degenerative spondylolisthesis.
These results imply that surgeons may consider either iliac crest
bone graft or graft that is not from the iliac crest for lumbar fusion, depending on their preference and the pathological findings
in the patient, without an increase in complications.
Appendix
A table showing the baseline patient demographic characteristics, comorbidities, and health status measures
according to the bone-graft source is available with the online
version of this article as a data supplement at jbjs.org. n
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